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Abstract
Described is the construction of a large array of releasable microstructures (micropallets) along
with screening and isolation protocols for sorting rare, approximately 1 in 10,000, cancer stem
cells (CSCs) from a heterogeneous cell population. A 10.1 × 7.1 cm array of micropallets (50 × 50
× 75 μm structures and 25 μm micropallet gap) was fabricated on a large glass substrate,
providing an array of approximately 1.3 million releasable microstructures. Image analysis
algorithms were developed to permit array screening for identification of fluorescently labeled
cells in less than 15 minutes using an epifluorescent wide-field microscope with a computer
controlled translational stage. Device operation was tested by culturing HeLa cells transfected
with green fluorescent protein (GFP) admixed with wild-type HeLa cells at ratios of 1:104 to 1:106
on the array followed by screening to identify flourescent cells. Micropallets containing cells of
interest were then selectively released by a focused laser pulse and collected on a numbered
poly(dimethylsiloxane (PDMS) substrate with high viability. A direct comparison of this
technology with fluorescence-activated cell sorting (FACS) demonstrated that micropallet arrays
offered enhanced post sorting purity (100%), yield (100%) and viability (94 – 100%) for rare cell
isolation. As a demonstration of the technology’s value, pancreatic tumor cells from Panc-1 cell
lines and patient-derived xenografts were screened for the presence of CD24, CD44 and CD326;
surface markers of pancreatic CSCs. Following cell isolation and culture, 63 ± 23% of the isolated
Panc-1 cells and 35% of sorted human xenograft cells formed tumor spheroids retaining high
expression levels of CD24, CD44 and CD326. The ability to isolate rare cells from relatively small
sample sizes will facilitate our understanding of cell biology and the development of new
therapeutic strategies.
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Cancer accounts for approximately 25% of deaths in the United States with most mortality
due to metastases.1,2 Growth of tumors at sites distant from the primary location arises from
intravasation of tumor cells followed by extravasation and growth in new locations. Only a
small percentage of tumor cells circulating in the blood stream are competent to engraft and
form new tumors.3,4,5 These successful cells are thought to possess stem cell-like attributes
which enable the cells to divide, reproducing additional cancer stem cells (CSCs).
Additionally, CSCs can differentiate into the proliferating cells comprising the tumor. CSCs
have been identified in many tumor systems including: breast cancer,6 prostate cancer,7 the
hematopoietic system8 and the central nervous system.9 Pancreatic ductal adenocarcinoma is
an important tumor clinically because death rates from individuals diagnosed with
pancreatic cancer remain high. A rare subset of cells with stem-like properties in pancreatic
cancer is characterized by expression of CD44, CD24 and CD326 surface markers.10
CD44+/CD24+/CD326+ cells have recently been reported to exhibit greater invasive and
proliferative properties than other cell populations and are competent to form tumors in
mouse xenograft models.10
Difficulties in monitoring and characterizing these CSCs occur due to their low abundance
in the heterogeneous tumor cell population. The majority of research directed at analyzing
and sorting these stem-like cells employs fluorescence-activated cell sorting (FACS).10,11
For successful FACS sorting of CSCs, the adherent tumor cells are stripped from their
growth surfaces, labeled with surface-marker specific antibodies and then isolated by FACS.
While FACS possesses high throughput (>10,000 cells/s), these systems are not effective at
isolating very rare target cells (frequencies below 0.01%).12 Isolation of rare cells by FACS
is often preceded by an enrichment step, such as magnetic-activated cell sorting (MACS),
prior to FACS for the best outcome.13,14,15 However, MACS becomes complicated when
selection of multiple surface markers is necessary, such is the case for the CD44+/CD24+/
CD326+ pancreatic CSCs. Several microfluidic technologies have recently been developed
to achieve isolation and analysis of rare cells. These systems utilize a wide variety of sorting
strategies including: immunocapture,16 magnetism,17 size,18 and dielectrophoresis.19,20
These strategies often offer low yields especially when sorting cells that normally grow
adherent to a surface. The methods require removal of adherent cells from their growth
surface which is accompanied by a change in the cell morphology, removal cellular surface
markers and markedly altered cell physiology. Sample preparation, cell manipulation and
loss of cell-surface contacts all lead to low recovery and viability when adherent cell types
are separated by these flow-based sorting strategies.21
Microscopy-based cell imaging devices eliminate challenges associated with examining
adherent cells in suspension by allowing analysis of cells while still attached to their growth
surfaces. Additionally, these methods permit evaluation of subcellular components, temporal
responses and cell-cell interactions. Several imaging cytometry systems have shown success
at enumerating rare cells.22,23 Unfortunately, few devices have successfully incorporated
cell sorting capabilities with high-throughput microscopy-based detection. The Allbritton
group has previously demonstrated the utility of arrays of releasable elements
microfabricated on glass substrates termed ‘micropallets’ for sorting single adherent cells
and small colonies while the cells remain attached to the micropallet suface.24 This
technology has shown success in sorting single cells present at a rarity down to 1% in a
mixed cell population with low reagent requirements and with a high post sorting yield and
viability.25 However, the minute quantity of many tumorigenic cancer cells intermixed with
a very large, heterogeneous cellular population makes standard micropallet arrays
(comprising 10,000 – 50,000 elements) ineffective platforms for isolating these cells. In the
present work, the potential for using micropallet arrays to sort rare cell types i.e. 1 cell per
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104 – 106 non-target cells, is examined. For these purposes, a large array of approximately
1.3 million micropallets was developed along with a high-throughput array screening
procedure. A high-resolution wide-field microscope and automated image processing were
utilized to identify low abundance target cells on the array. Isolation of viable rare cells by
the micropallet arrays was achieved and results were directly compared to FACS sorting.
This system was then employed to sort and culture viable CSCs from both the Panc-1 cell
line and pancreatic tumor cells acquired from patient-derived xenograft mice models.
Experimental Section
Fabrication of micropallet arrays and PDMS chambers
Large arrays of micropallets composed of 0.25% magnetic 1002F photoresist were
fabricated on 150 mm diam. B270 glass slides (Valley Design Corp., Santa Cruz, CA) as
described in the Supporting Information.26 Large arrays were composed of a 1350 × 950
array of micropallets with dimensions of 50 × 50 × 75 μm (L × W × H) and a 25 μm gap
between micropallets. This generated an array with a total size of 101.2 × 71.3 mm
consisting of 1,280,448 micropallets with 513 marker or numbered micropallets. Following
micropallet fabrication, a plastic cassette was glued around the micropallet array with
poly(dimethylsiloxane (PDMS). The array was coated with hydrophobic
perfluoroalkylsilane layer ((heptadecafluoro-1,1,2,2-tetrahydrodecyl) trichlorosilane) by
chemical vapor deposition as described previously.27 The arrays were sterilized by rinsing
with 95% ethanol and dried in a tissue culture hood. Excess ethanol was removed with 5
phosphate buffered saline (PBS) rinses. Top surfaces of the micropallets on the array were
then coated with fibronectin by incubation with 5 mL of 25 μg/mL fibronectin in PBS for
one hour at room temperature. For attachment of primary cells, micropallets were pre-
incubated with 1% matrigel in PBS for at least one hour at 37°C. Following surface coating,
the array was rinsed ×5 with 1X PBS.
Cell culture
HeLa (a human ovarian carcinoma cell line), GFP-HeLa (HeLa cells stably transfected with
a fusion protein of histone-H1 and green fluorescent protein [GFP]) and Panc-1 (an
epitheliod carcinoma cell line from human pancreas) cells were cultured on a 75 cm2 cell
culture flask in DMEM supplemented with FBS (10%), L-glutamine (584 mg L−1),
penicillin (100 units mL−1) and streptomycin (100 μg ml−1) in a 37°C incubator with a 5%
CO2 atmosphere. Cells were detached from the substrate with 0.25% trypsin in media
followed by centrifugation at 800 rcf for 2 min. The supernatant was subsequently removed
and replaced by 10 mL media. At this point the cell suspension was passed through a 40 μm
sterile cell strainer and cells counted with a hemocytometer.
To culture cells on the micropallet arrays, the 1X PBS was replaced with cell culture media
and suspensions of HeLa cells intermixed with various quantities of GFP-HeLa cells were
added to the array at a cell:micropallet ratio yielding <1 cell per micropallet (10 mL of
40,000 cells/mL). Cells were allowed to settle and adhere to the array for 8 h unless
otherwise stated in the text. Arrays were then rinsed with PBS and imaged for the presence
of target cells. Following cell identification, micropallets carrying cells of interest were
released from the array with a laser pulse and magnetically collected, as described in
Supporting Information. Waste collected from the arrays following cell imaging was
collected in a petri dish and manually imaged to count any non-adherent cells. The number
of cells counted on the array divided by the total number of cells loaded (enumerated cells
plus cells counted in waste) was calculated to determine capture efficiencies.
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A computer-controlled (ProScan III motorized stage system, Prior Scientific Inc., Rockland,
MA) XY translational stage (H138A/C ProScan upright microscope stage, Prior Scientific
Inc., Rockland, MA) was mounted on an Olympus MVX10 MacroView microscope
(Olympus, Center Valley, PA) with a Hamamatsu ORCA-Flash4.0 CMOS camera
(Hamamatsu, Bridgewater, NJ) for imaging. Focus adjustments were controlled by a
motorized focus drive (ProScan™ III motorized focus control, Prior Scientific Inc.,
Rockland, MA). Automated array screening was achieved through a custom MATLAB
program (Figure S1). The boundaries and focal plane of the array were identified, then the
array was screened with a 1X objective and 2X zoom which generated 166 individual 6.85 ×
6.85 mm images consisting of 8,100 micropallets each. Micropallet arrays were imaged in a
raster scan pattern with brightfield microscopy and fluorescence microscopy using blue (Ex.
350±25nm, Dichroic 400, Em. 460±25nm), green (Ex. 470±20, Dichroic 495, Em. 525±25),
red (Ex. 545±15, Dichroic 570 Em. 620±30) and/or far red (Ex. 620±60, Dichroic 660, Em.
810±75) fluorescent filter sets; fluorescence illumination was achieved via a Lumen 200 arc
lamp (Prior Scientific Inc., Rockland, MA). Following image acquisition, images were
processed and analyzed for the presence of target cells by a custom MATLAB program as
described in Supporting Information (Figure S6).
Fluorescence-activated cell sorting (FACS)
GFP-HeLa cells were mixed with HeLa cells at ratios of 1:104, 1:105 and 1:106 in complete
media. For the 1:104 and 1:105 ratios, a total of 1,000,000 cells were used while 4 × 106
cells were employed for the 1:106 mixture. The cell mixtures were then split into two
aliquots, one to be separated by FACS and the other cultured on the micropallet arrays with
the goal of isolating the GFP-HeLa cells. For FACS, cells were separated based on forward
and side scatter and GFP fluorescence using a singlet-cell gate and 100 μm tip (MoFlo,
Beckman-Coulter, Brea, CA). Single cells were deposited into wells of a 96 well glass
bottom plate preloaded with 100 μL of conditioned media (Auto Clone, Beckman-Coulter,
Brea). Wells with cells were identified by microscopy and cultured in conditioned media for
7 days. After that time, the cells were again examined and colony formation was determined.
In addition to the aliquot of cells to be sorted, the FACS system also utilized an additional
10,000 cells (50:50 HeLa/GFP-HeLa) to set the sort parameters.
Mouse Pancreatic Tumor Models
All animal studies were approved by University of North Carolina at Chapel Hill Animal
Care and Use Committee and comply with National Institute of Health guidelines. Cells
were obtained from patient-derived xenograft mouse models of pancreatic
adenocarcinoma.28 Tumors were harvested and washed with PBS. The sample was then
disaggregated by mincing with a sterile razor followed by incubation for 20 min at 37°C in
100 μL of combined collagenase D + Dispase II solution (40 mg/mL each) in RPMI media
with 10% FBS and 1X Penicillin/Streptomicin (P/S). Following incubation, an additional 1
mL media was added and the cells were centrifuged at 1800 rcf for 2 min in a conical tube.
The supernate was then removed and cells resuspended in 10 mL of DMEM containing 10%
FBS, 1X P/S, 1 ng/mL insulin growth factor (IGF) and 1 ng/mL epidermal growth factor
(EGF) followed by passage through a 40 μm sterile cell strainer (BD Falcon, Franklin
Lakes, NJ).
Cell Staining
Following attachment of Panc-1 or xenograft cells to the micropallet tops, the arrays were
washed 3× with PBS. An antibody cocktail (consisting of 10 μg/mL anti-CD24
[phycoerythrin (PE)], 10 μg/mL anti-CD44 [fluorescein isothiocyanate] and 10 μg/mL anti-
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CD326 [AlexaFluor 647]) in cell staining buffer was incubated on the arrays at 4°C for 20
min. Micropallet arrays were then rinsed twice with PBS and covered with a sterile glass
slide for imaging.
RESULTS AND DISCUSSION
Design of large-scale micropallet arrays
To identify cells occurring at frequencies as low as 1 in 106, arrays accommodating large
numbers of cells were fabricated. Arrays (10.1 × 7.1 cm) with 1.3 million micropallets (50 ×
50 × 75 μm (L × W × H), 25 μm interpallet gap) were fabricated on a glass substrate (Figure
1B).24 Every 50th and 51st element was replaced with a single 125 × 125 μm square
micropallet imprinted with numbers to assist in identifying micropallet location on the array.
The micropallets were composed of 1002F photoresist with 0.25% γFe2O3 nanoparticles
wt./wt. to enable efficient collection of released elements within a magnetic field.26 These
large-scale arrays contained 130 times the number of micropallets as a standard size
micropallet arrays (10,000 micropallets). This substantially reduced the fabrication costs,
time and reagents necessary for assaying large numbers of cells.
Image acquisition
Screening of large-scale arrays for rare events requires an efficient means of imaging the
array and identifying cells of interest. Numerous factors should be addressed when
developing a system for high-throughput imaging including: screening duration, cellular
fluorescence intensity and pixel number per cell. A widefield fluorescence microscope was
employed to generate high resolution images at low magnification. To automate image
acquisition, the camera, microscope stage and focus adjustments were controlled by a
customized MATLAB program. The efficiency of system automation was assessed by
screening a 10.1 cm × 7.1 cm micropallet array as described in the Supporting Information
(Image acquisition). Multiple combinations of microscope objectives and magnifications
were examined to evaluate pixel resolution and scan speed. An array screening time of less
than 5 min and a resolution of ≤5 μm/pixel were picked as metrics to ensure rapid
acquisition of high quality images. A 1X objective with 2X magnification (166 images/
array, 8,100 micropallets/image) yielded the most acceptable compromise between
resolution (3.34 μm/pixel), image acquisition time (3 min 51 s) and detection sensitivity
(100%) (Table S1). This configuration allowed four sequential images of the array in to be
acquired in less than 15 min.
Imaging workflow
A defined series of steps were integral in automating micropallet array screening, image
processing and cell identification (Figure 1A). Initially, the system parameters were user
defined in a graphical user interface (GUI) that included selection of the number of
wavelengths, exposure times, size exclusion limits and threshold method (Figure S1). The
boundaries (X–Y axis) of the micropallet array were set by imaging and software-based
marking of the array corners under brightfield microscopy. Although the glass slide and
microscope stage have excellent flatness, micron size particles on either surface often
skewed the surface plane of the array by several microns over the array length.
Simultaneously, while marking the array boundary, the microscope was focused on the
micropallet tops. Principal component analysis (PCA) was then utilized to define a planar fit
of the array surface. This provided the Z position for each micropallet so that the image
plane always coincided with the micropallet surface during array scanning. The micropallet
array was then sequentially screened using both brightfield and fluorescence microscopy.
Brightfield images were acquired to aid in cell identification and to report micropallet
addresses using the numbered micropallets (Figure 1C). Fluorescence images were attained
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at the appropriate fluorescence wavelength for the fluorophore (EGFP in this case) within
the target cells and at irrelevant wavelengths (blue and red emission). The irrelevant
wavelengths were used to aid in identification of debris that was either highly scattering or
fluorescent (Figure S3). In general the debris generated a light signal that reached the
camera at all three excitation/emission wavelengths. Thus bright objects at the irrelevant
wavelengths (blue and red) were likely artifacts that could be ignored despite producing a
measurable signal at the same excitation/emission wavelengths as EGFP. The system
parameters for imaging a 10.1 × 7.1 cm array were optimized by screening an array
containing 100,000 GFP-HeLa cells intermixed with HeLa cells (Figure 1C-D). GFP-HeLa
cells were utilized as target cells due to their high, stable fluorescence intensity. The array
was imaged at three different excitation/emission wavelengths to create blue, green and red
fluorescence images of the array. Imaging parameters were optimized for their effectiveness
in correctly identifying GFP-HeLa cells while minimizing false positive reports as described
below.
Image processing
Prior to cell identification, image acquisition and pre-processing of raw images was
necessary to reduce background noise in the green image. Reduction in the background
signals resulting from small air bubbles and autofluorescence of the micropallets were
predicted to improve discrimination between target cells and artifacts during image analysis.
Image acquisition and processing were optimized by controlling the fluorescence exposure
intensity and by applying noise filtering and background subtraction on the images as
described in detail in Supporting Information (Image processing). Exposure times were
evaluated for their ability to generate the greatest S/N ratio in the shortest duration; an
optimal exposure duration for the green image set was determined to be 182 ± 7 (see
Supporting Information – Image processing) (Figure S2).
Increases in S/N were further attained by performing noise filtering and background
subtraction on the green images.29 Following image capture, five different methods were
tested to increase the S/N for the green images; adaptive Wiener filtering, top hat filtering,
modified top hat filtering and a combination of these strategies (Table S2).30 The modified
top hat filter without adaptive Wiener filtering provided the greatest increase in the S/N (77
± 7) with respect to the original image (S/N 40 ± 3) (Figure S4D). In essence, the modified
top hat filter generated the best background approximation that could be subtracted from the
raw image. This image processing strategy was employed prior to data analysis in all
subsequent experiments.
Image analysis
To quickly identify cells on the array, background subtracted images were thresholded to
remove signals with low intensity and further processed to eliminate debris. Thresholding
algorithms were screened for their effectiveness at achieving high sensitivity while
minimizing false positive reports, as described in Supporting Information (Imaging analysis
– Image thresholding). Four 11.7 mm2 micropallet array images were acquired possessing a
total 159 ± 47 user-defined GFP-HeLa cells each. An ideal threshold was determined to be
the largest value that yielded 0% false negatives. False positives were tolerated since the
goal was to identify 100% of the target cells, while the true positives could be rapidly
identified by manual screening of the objects exceeding the threshold value. Manual setting
of the threshold yielded a false positives number of 5 ± 2 per image for the four images
(Figure S5).
While manually setting a fluorescence threshold cutoff value allowed accurate identification
of target cells, this strategy suffered from the same limitations as flow cytometry threshold
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selection methods: a high concentration of control cells were necessary to efficiently
calibrate detection. This approach can be challenging when the target cells are extremely
rare and positive controls are not available. For this reason we investigated automated
thresholding techniques (Table S3). Six different thresholding algorithms (K-Means
clustering, Histogram Trough, Kapur Entropy, Mean, Yen Entropy and Li Entropy) were
examined for their ability to identify thresholds which provided 100% sensitivity and
minimized false positives as described in Supporting Information (Image Analysis –
Automated thresholding).31 The algorithms selected required minimal image processing
times and were easily implemented in MATLAB. The ‘Kapur Entropy’ thresholding
algorithm was the only algorithm to accurately select 100% of the true positives for the
green image while maintaining a low numbers of false positive objects (13 ± 4). This
entropic thresholding method iteratively selects a threshold value that maximizes the sum of
the entropies above and below the threshold.32 The false positives identified in the green
image were due to objects that intensely scattered light.
In addition to removal of objects below threshold cutoffs, intensely fluorescent or scattering
debris was eliminated from the green image by identifying bright objects in the red and blue
images. The red and blue images were processed in a manner similar to the green image to
identify bright objects (Figure 1A). The coordinates of bright entities identified in the blue
and red images were used to exclude these objects from consideration in the green image
decreasing the number of false positives from the ‘Kapur Entropy’ thresholded image by 57
± 10% (7 ± 4 false positives remaining).
Another common strategy for removing unwanted signals during imaging cytometry is to
apply sized-based filtering to the thresholded image. When a size filter (5 μm < x < 40 μm
diameter) was applied to the ‘Kapur Entropy’ thresholded images to remove objects outside
of the size range of a GFP-HeLa cell, 40 ± 14% (8 ± 2 false positives remaining) of the false
positive results were eliminated, while all true positives were detected. The minimal pixel
count per cell, as determined above, must be >1 to permit removal of small artifacts. To
further minimize false positive counts, both the scatter and size filters were applied in
succession. This strategy reduced the false positive number by 75 ± 8% (4 ± 2 false
positives remaining) while still identifying all true positives. Following imaging analysis,
target cell coordinates were reported by correlating their absolute position on the XY stage
relative to the numbered micropallets imprinted on the array. This allowed the user to
quickly screen through the objects of interest at a higher magnification and confirm true
positives.
Isolation of rare cells by micropallet technology vs FACS
A direct comparison of micropallet sorting with FACS for sorting 103 or 106 cells when the
ratio of target fluorescent cells to background cells was 1:99 has been previously reported.25
The FACS system was unable to isolate cells when loaded with 103 cells but could
efficiently isolate target cells from samples composed of 106 cells. Here a comparison was
made between the micropallet technology and FACS for isolating very rare target cells.
Standard mixtures of GFP-HeLa cells and HeLa cells at ratios of 1:104, 1:105 and 1:106
were generated and split into two aliquots for analysis by each technology. Half the samples
(500,000 cells for the ratios of 1:104 and 1:105, and 2,000,000 cells for the ratio of 1:106)
were sorted using the micropallet arrays, and in parallel experiments the other half of the
sample was sorted by FACS.
Micropallet arrays were imaged and GFP-HeLa cells identified using the automated image
analysis software described above (Fig. 2). The identified objects were then manually
examined to determine whether the cells expressed GFP. GFP-HeLa cells were flagged in
the samples with efficiencies of 100% (48 cells), 100% (5 cells) and 100% (2 cells) for the
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target to background cell ratios of 1:104, 1:105 and 1:106, respectively (Figure 2G). The
optimized image processing and analysis gave on average 468 ± 80 false positive signals
over a total of 6 arrays analyzed (7.8 million micropallets). Along with the fluorescence-
based target identification, the array was imaged with brightfield microscopy to ascertain the
coordinates of the target cells. Numbered micropallets were distributed throughout the array
so that the micropallets with GFP-HeLa cell could be readily assigned addresses (Fig. 2A–
B). The GFP-HeLa cells identified above were each detached from the array and
magnetically collected into numbered PDMS multiwell plates with 100% collection
efficiency (Fig. 2C–D). After 7 days of culture, 45, 5 and 2 of the single GFP-HeLa cells
formed small colonies from the collected micropallets (for the target cell ratios of 1:104,
1:105 and 1:106, respectively) (Fig. 2E–G). No non-fluorescent HeLa cells were present on
the collection plate, indicating that there were no false-negative identifications and a sorting
purity of 100%.
The FACS system was very accurate at identifying the GFP-HeLa cells; however,
calibration with a concentrated cell suspension was required prior to cell sorting to set gating
thresholds. Target cells were sorted into individual chambers of a 96 well plate and cultured
for 7 days (Fig. 2G). When imaged for the presence of colony formation, 5 colonies were
observed for the 1:104 mixture (50 cells sorted), no cell colonies were present for the 1:105
mixture (5 cells sorted) and no colonies formed from the 1:106 mixture (2 cells sorted) (Fig.
2G). High cell loss and low collection viability are common drawbacks of FACS which
result in low sorting yields for very rare cells. These weaknesses are the basis for the general
recommendation that FACS systems not be used for isolating single cells from mixtures at
frequencies less than 0.01%.13 Instead, rare cell isolation by FACS typically requires
repeated rounds of enrichment applying substantial stresses to cells. Conversely, cells sorted
by micropallet arrays formed colonies with excellent efficiency (94 – 100%). The ability to
adjust the imaging analysis parameters during or following image acquisition and prior to
sorting decisions provides high sorting efficiencies of unknown rare specimens which are
not feasible with single time-frame sorting techniques such as FACS and microfluidics.
These results suggested that large arrays of micropallets combined with sensitive image
acquisition and analysis can efficiently enumerate and isolate low abundance cells.
Isolation of Panc-1 cancer stem cells
The above results suggest that micropallet technology might be used to isolate low
abundance cells such as CSCs from a heterogeneous cell population. Reduction to practice
was implemented by sorting cells expressing surface markers indicative of being CSCs from
the Panc-1 cell line. A single cell suspension of 400,000 Panc-1 cells was cultured on a
micropallet array for 12 h (n = 3). Cells on the arrays were stained with antibodies defining
CSCs: phycoerythrin (PE)-labeled anti-CD24, fluorescein-labeled anti-CD44 and Alexa
Fluor 647-labeled anti-CD326.10 The arrays were imaged and CSCs identified with the
automated software as those cells positive for PE, fluorescein and Alexa Fluor 647 but not
fluorescent in the blue wavelengths (Fig. 3A). In these analyses, 0.003 ± 0.002% (approx. 1
in 30,000) of the cells were found to be CSCs. Positive cells (n = 43) were then released
from the arrays and collected into a multiwell plate coated with matrigel. Following 7 days
of culture, collected micropallets were examined for the presence of small CSC colonies. 32
of the isolated cells formed colonies (78 ± 10%). Of these 32 colonies, 24 colonies (63 ±
23%) exhibited a spheroid phenotype with high surface expression of CD24, CD44 and
CD326 indicating that they were CSCs (Fig. 3B). The remaining colonies lost expression of
at least one of the CSC surface markers and typically exhibited an adherent phenotype with
cells spreading across the substrate. These data indicate that low-abundance cells with CSC
characteristics can be isolated and cultured maintaining the CSC-marker antigens during
culture.
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Isolation of pancreatic cancer stem cells from patient-derived xenografts
Clinical tumors possess considerably greater cellular heterogeneity than that of cultured cell
lines. We therefore evaluated the ability of the micropallet technology to identify and isolate
CSCs from patient-derived xenografts of pancreatic adenocarcinoma. Patient-derived
xenografts retain the genetic and phenotypic properties of the primary human tumor making
this xenograft system an excellent model system for human cancer.33 Tumors propagated in
nude mice were enzymatically disaggregated and filtered to create a single cell suspension.
Micropallets were coated with matrigel and 400,000 tumor cells were cultured for 2 days on
the array. The array was then incubated with PE-labeled anti-CD24, fluorescein-labeled anti-
CD44 and Alexa Fluor 647-labeled anti-CD326. The array was scanned using the automated
software to identify cells that were CD24+/CD44+/CD326+. Fifty cells (0.0125% of the cells
cultured) exhibited a CSC phenotype (Fig. 3C). Twenty micropallets with CSCs were then
released and collected into a PDMS multiwell plate coated with matrigel. The wells were
examined for the presence of small colonies following 7 days of culture. Of the collected
cells, 12 (60%) formed small colonies of which 7 (35%) had a mammospheroid phenotype
and retained a high surface expression of CD24, CD44 and CD326 (Fig. 3D). These results
correlate well with previous studies demonstrating enhanced long term in vitro culture of
stem-like cells by mammosphere cell culture.34 The procedures outlined above for isolating
pancreatic CSCs could easily be adapted to sort CSCs from other tissues and by different
surface markers. High efficiency isolation and culture of CSC colonies from individual
primary tumor cells enabled by the micropallet technology could improve current research
evaluating the biology and drug susceptibility of CSCs.
CONCLUSIONS
An array in excess of 1 million micropallets was developed for capturing and isolating rare
cells from a heterogeneous mixture. Image processing and analysis were automated to
rapidly identify cells on the array. Important factors in the successful identification of rare
cells include the camera exposure time, image background subtraction, threshold selection
and reduction of false positives by size-based filtering and negative control images at
irrelevant wavelengths. Efficient sorting of adherent cells expressed at abundances down to
one in a million was demonstrated with this technology. The ability to isolate rare cells
without the need for multiple rounds of sorting will allow new biological applications since
low-abundance cells are readily obtained. Though automated screening of the array was
performed in <15 min, the precise micropallet positions were manually recorded and the
arrays were transferred to an inverted microscope for user-controlled release of select
micropallets. Incorporation of the laser-based released system and more advanced analysis
software onto the same platform system would enable fully automated array screening and
microstructure release. The strength of the micropallets arrays is the potential to maintain
segregation between slow and fast growing cells due the very large size of the culture
surface. This should permit the separation of slow growing or non-proliferating cells
intermixed with fast growers, a feat not easily accomplished with other methods in which
the rapidly growing cells overgrow other cell types, such as cells overexpressing a tumor
suppressor or other growth inhibiting protein. The technology might also be adapted to
isolate viable circulating tumor cells from whole blood without requiring lysis of the
erythrocytes and lymphocytes. The strategies developed in this report to quickly scan and
analyze a large area will be of utility in identifying cells on other large-scale culture
platforms.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Image acquisition and analysis. (A) Schematic of the process flow for image acquisition,
data analysis and cell identification. Imaging criteria for scanning the micropallet array is
first entered into a ScanArray GUI that controls imaging by brightfield and fluorescence
microscopy. Images are then processed with a combination of background subtraction,
thresholding, size-based filtering and negative control filtering to identify target cells.
Micropallets carrying specified cells are then selectively detached from the array and
magnetically collected. (B) Photograph of large micropallet array. A U.S. quarter is shown
next to the array for size comparison. (C–D) Micrographs of HeLa cells admixed with a low
abundance of GFP-HeLa cells on micropallets. Brightfield and fluorescence images show
identification of a single GFP-HeLa cell. Insets show the GFP-HeLa at higher
magnification. The ‘star’ highlights array regions with water infiltration around the
micropallets.
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Isolation of low-abundance cells. (A–B) Brightfield and fluorescence images of a GFP-
HeLa cell present in an excess of wild-type HeLa cells at a ratio of 1:106. The same cell is
shown following micropallet release and collection (C-D) and culture for 7 days (E-F). (G)
Efficiencies of low-abundance GFP-HeLa cell sorting by micropallet arrays and FACS.
GFP-HeLa cells admixed into a population of HeLa cells at frequencies of 10−6 – 10−4 were
detected using micropallet technology (solid black triangles) and FACS (open black
triangles). Following sorting into a multiwell plate by micropallet techology (solid blue
squares) or FACS (open blue diamonds) the proliferation was recorded as the percentage of
cells that formed small colonies after 7 days incubation.
Gach et al. Page 13














Isolation of pancreatic cancer stem cells. Brightfield and corresponding fluorescence images
for fluorescein-labeled anti-CD44, PE-labeled anti-CD24 and Alexa Fluor 647-labeled anti-
CD326. (A) Images of a CD44+/CD24+/CD326+ Panc-1 cell on a micropallet and (B) same
cell after isolation and 7 days of culture. (C) Images of a CD44+/CD24+/CD326+ human
pancreatic tumor xenograft cell on a micropallet and (D) resulting cell colony following
isolation and 7 days of culture. Scale bars are 50 μm.
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